Hepatitis E virus: New faces of an old infection

Annals of Hepatology

Volumn 12, Issue 6, 2013, Pages 861-870

  Riveiro Barciela, Mar ^a   Rodríguez Frías, Francisco ^b,c   Buti, María ^a,c  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Diagnosis; Epidemiology; Manifestations; Treatment; Vaccine

Indexed keywords

HEPATITIS E VACCINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PEGINTERFERON; RIBAVIRIN;

ANEMIA; ARTICLE; BONE MARROW SUPPRESSION; DRUG WITHDRAWAL; GRAFT RECIPIENT; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; LIVER CIRRHOSIS; LIVER FIBROSIS; MORBIDITY; MORTALITY; OPEN READING FRAME; VIRUS TRANSMISSION;

ACUTE DISEASE; ANTIVIRAL AGENTS; HEPATITIS E; HEPATITIS, CHRONIC; HUMANS; RISK FACTORS; TREATMENT OUTCOME; VIRAL HEPATITIS VACCINES;

EID: 84890089807     PISSN: 16652681     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1665-2681(19)31290-6     Document Type: Article

References (94)

1. WHO. Viral Hepatitis Statement A62/22. Available from: http:/apps.who.int/gb/ebwha/pdf_files/A62/A62_22-en.pdf
2. Purcell RH, Emerson SU. Hepatitis E: an emerging awareness of an old disease. J Hepatol 2008; 48: 494-503.
3. Dalton HR, Bendall R, Ijaz S, Banks M. Hepatitis E: an emerging infection in developed countries. Lancet Infect Dis 2008; 8: 698-709.
4. Vishwanathan R. Infectious hepatitis in Delhi (1955-56), a critical study: epidemiology. Indian J Med Res 1957; 45: 49-58.
5. Balayan MS, Andjaparidze AG, Savinskaya SS, Ketiladze ES, Braginsky, DM, Savinov AP, Poleschuk VF. Evidence for a virus in non-A, non-B hepatitis transmitted via the fecaloral route. Intervirology 1983; 20: 23-31.
6. Bihl F, Negro F. Hepatitis E virus: a zoonosis adapting to humans. J Antimicrob Chemother 2010; 65: 817-21.
7. Kamar N, Selves J, Mansuy JM, Ouezzani L, Péron JM, Guitard J, Cointault O, et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med 2008; 358: 811-7.
8. Gérolami R, Moal V, Colson P. Chronic hepatitis E with cirrhosis in a kidney-transplant recipient. N Engl J Med 2008; 358: 859-60.
9. Gérolami R, Moal V, Picard C, Colson P. Hepatitis E virus as an emerging cause of chronic liver disease in organ transplant recipients. J Hepatol 2009; 50: 622-4.
10. Kamar N, Garrouste C, Haagsma EB, Garrigue V, Pischke S, Chauvet C, Dumortier J, et al. Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. Gastroenterology 2011; 140: 1481-9.
11. Halac U, Béland K, Lapierre P, Patey N, Ward P, Brassard J, Houde A, et al. Chronic hepatitis E infection in children with liver transplantation. Gut 2012; 61: 597-603.
12. Haagsma EB, van den Berg AP, Porte RJ, Benne CA, Vennema H, Reimerink JH, Koopmans MP. Chronic hepatitis E virus infection in liver transplant recipients. Liver Transpl 2008; 14: 547-53.
13. Mallet V, Nicand E, Sultanik P, Chakvetadze C, Tessé S, Thervet E, Mouthon L, et al. Brief communication: case reports of ribavirin treatment for chronic hepatitis E. Ann Intern Med 2010; 153: 85-9.
14. Pischke S, Stiefel P, Franz B, Bremer B, Suneetha PV, Heim A, Ganzenmueller T, et al. Chronic hepatitis e in heart transplant recipients. Am J Transplant 2012; 12: 3128-33.
15. Kamar N, Rostaing L, Abravanel F, Garrouste C, Lhomme S, Esposito L, Basse G, et al. Ribavirin therapy inhibits viral replication on patients with chronic hepatitis e virus infection. Gastroenterology 2010; 139: 1612-8.
16. Chaillon A, Sirinelli A, De Muret A, Nicand E, d'Alteroche L, Goudeau A. Sustained virologic response with ribavirin in chronic hepatitis E virus infection in heart transplantation. J Heart Lung Transplant 2011; 30: 841-3.
17. Wedemeyer H, Pischke S, Manns MP. Pathogenesis and treatment of hepatitis e virus infection. Gastroenterology 2012; 142: 1388-97.
18. Kamar N, Weclawiak H, Guilbeau-Frugier C, Legrand-Abravanel F, Cointault O, Ribes D, Esposito L, et al. Hepatitis E virus and the kidney in solid-organ transplant patients. Transplantation 2012; 93: 617-23.
19. de Niet A, Zaaijer HL, ten Berge I, Weegink CJ, Reesink HW, Beuers U. Chronic hepatitis E after solid organ transplantation. Neth J Med 2012; 70: 261-6.
20. Koning L, Pas SD, de Man RA, Balk AH, de Knegt RJ, ten Kate FJ, Osterhaus AD, et al. Clinical implications of chronic hepatitis E virus infection in heart transplant recipients. J Heart Lung Transplant 2013; 32: 78-85.
21. Riezebos-Brilman A, Puchhammer-Stöckl E, van der Weide HY, Haagsma EB, Jaksch P, Bejvl I, Niesters HG, et al. Chronic hepatitis E infection in lung transplant recipients. J Heart Lung Transplant 2013; 32: 341-6.
22. Pischke S, Hardtke S, Bode U, Birkner S, Chatzikyrkou C, Kauffmann W, Bara CL, et al. Ribavirin treatment of acute and chronic hepatitis E: a single-centre experience. Liver Int 2013; 33: 722-6.
23. Alric L, Bonnet D, Palacin A, Thébault S, Peron JM, Sigur N, Nicot F, et al. Comparison of virological response between ribavirin and Peg-interferon monotherapy during autochtonous chronic hepatitis E virus infection. J Hepatol 2013; 58: S499.
24. Colson P, Kaba M, Moreau J, Brouqui P. Hepatitis E in an HIV-infected patient. J Clin Virol 2009; 45: 269-71.
25. Dalton HR, Bendall RP, Keane FE, Tedder RS, Ijaz S. Persistent carriage of hepatitis E virus in patients with HIV infection. N Engl J Med 2009; 361: 1025-7.
26. Dalton HR, Keane FE, Bendall R, Mathew J, Ijaz S. Treatment of chronic hepatitis E in a patient with HIV infection. Ann Intern Med 2011; 155: 479-80.
27. Kenfak-Foguena A, Schöni-Affolter F, Bürgisser P, Witteck A, Darling KE, Kovari H, Kaiser L, et al, and the Data Center of the Swiss HIV Cohort Study, Lausanne, Switzerland. Hepatitis E Virus seroprevalence and chronic infections in patients with HIV, Switzerland. Emerg Infect Dis 2011; 17: 1074-8.
28. Crum-Cianflone NF, Curry J, Drobeniuc J, Weintrob A, Landrum M, Ganesan A, Bradley W, et al; Infectious Disease Clinical Research Program HIV Working Group. Hepatitis E virus infection in HIV-infected persons. Emerg Infect Dis 2012; 18: 502-6.
29. Curry JA, Adams N, Crum-Cianfl one NF. Acute hepatitis E infection in an HIV-infected person in the United States. Ann Intern Med 2009; 150: 226-7.
30. Keane F, Gompels M, Bendall R, Drayton R, Jennings L, Black J, Baragwanath G, et al. Hepatitis E virus coinfection in patients with HIV infection. HIV Med 2012; 13: 83-8.
31. Renou C, Lafeuillade A, Cadranel JF, Pavio N, Pariente A, Allègre T, Poggi C, et al. Hepatitis E virus in HIV-infected patients. AIDS 2010; 24: 1493-9.
32. Madejón A, Vispo E, Bottecchia M, Sánchez-Carrillo M, García-Samaniego J, Soriano V. Lack of hepatitis E virus infection in HIV patients with advanced immunodeficiency or idiopathic liver enzyme elevations. J Viral Hepat 2009; 16: 895-6.
33. Jardi R, Crespo M, Homs M, Van den Eynde E, Girones R, Rodriguez J, Caballero A, et al. HIV, HEV and cirrhosis: evidence of a possible link from eastern Spain. HIV Med 2012; 13: 379-83.
34. Péron JM, Mansuy JM, Récher C, Bureau C, Poirson H, Alric L, Izopet J, et al. Prolonged hepatitis E in an immunocompromised patient. J Gastroenterol Hepatol 2006; 21: 1223-4.
35. Tamura A, Shimizu YK, Tanaka T, Kuroda K, Arakawa Y, Takahashi K, Mishiro S, et al. Persistent infection of hepatitis E virus transmitted by blood transfusion in a patient with T-cell lymphoma. Hepatol Res 2007; 37: 113-20.
36. Alric L, Bonnet D, Beynes-Rauzy O, Izopet J, Kamar N. Definitive clearance of a chronic hepatitis E virus infection with ribavirin treatment. Am J Gastroenterol 2011; 106: 1562-3.
37. Ollier L, Tieulie N, Sanderson F, Heudier P, Giordanengo V, Fuzibet JG, Nicand E. Chronic hepatitis after hepatitis E virus infection in a patient with non-Hodgkin lymphoma taking rituximab. Ann Intern Med 2009; 150: 430-1.
38. De Silva S, Hassan-Ibrahim MO, Austin M, Newport M, Verma S. Hepatitis E infection is an under recognized cause of acute decompensation in patients with chronic liver disease. Dig Liver Dis 2012; 44: 930-4.
39. Goyal R, Kumar A, Panda SK, Paul SB, Acharya SK. Ribavirin therapy for hepatitis E virus-induced acute on chronic liver failure: a preliminary report. Antivir Ther 2012; 17: 1091-6.
40. Borkakoti J, Hazam RK, Kar P. Hepatitis E virus: A hidden danger in acute on chronic liver failure. J Hepatol 2013; 58: S499-S500.
41. Reyes GR, Purdy MA, Kim JP, Luk KC, Young LM, Fry KE, Bradley DW. Isolation of a cDNA from the virus responsible for enterically transmitted non-A, non-B hepatitis. Science 1990; 247: 1335-9.
42. Tam AW, Smith MM, Guerra ME, Huang CC, Bradley DW, Fry KE, Reyes GR. Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome. Virology 1991; 185: 120-31.
43. Xing L, Li TC, Mayakaki N, Simon MN, Wall JS, Moore M, Wang CY, et al. Structure of hepatitis E virion-sized particle reveals an RNA-dependent viral assembly pathway. J Biol Chem 2010; 285: 33175-83.
44. Lu L, Li C, Hagedorn CH. Phylogenetic analysis of global hepatitis E virus sequences: genetic diversity, subtypes and zoonosis. Rev Med Virol 2006; 16: 5-36.
45. Meng XJ, Purcell RH, Halbur PG, Lehman JR, Webb DM, Tsareva TS, Haynes JS, et al. A novel virus in swine is closely related to the human hepatitis E virus. Proc Natl Acad Sci USA 1997; 94: 9860-5.
46. Colson P, Romanet P, Moal V, Borentain P, Purgus R, Benezech A, Motte A, et al. Autochthonous infections with hepatitis e virus genotype 4, France. Emerg Infect Dis 2012; 18: 1361-4.
47. Jeblaoui A, Haim-Boukobza S, Pause S, Mokhtari C, Nicand E, Roque-Afonso AM. Emerging hepatitis E genotype 4 infection in France. J Hepatol 2013; 58: S405.
48. Colson P, Coze C, Gallian P, Henry M, De Micco P, Tamalet C. Transfusion-associated hepatitis E, France. Emerg Infect Dis 2007; 13: 648-9.
49. Boxall E, Herborn A, Kochethu G, Pratt G, Adams D, Ijaz S, Teo CG. Transfusion-transmitted hepatitis E in a 'nonhyperendemic' country. Transfus Med 2006; 16: 79-83.
50. Matsubayashi K, Kang JH, Sakata H, Takahashi K, Shindo M, Kato M, Sato S, et al. A case of transfusion-transmitted hepatitis E caused by blood from a donor infected with hepatitis E virus via zoonotic food-borne route. Transfusion 2008; 48: 1368-75.
51. Haïm-Boukobza S, Ferey MP, Vétillard AL, Jeblaoui A, Pélissier E, Pelletier G, Teillet L, et al. Transfusion-transmitted hepatitis E in a misleading context of autoimmunity and drug-induced toxicity. J Hepatol 2012; 57: 1374-8.
52. Schlosser B, Stein A, Neuhaus R, Pahl S, Ramez B, Krüger DH, Berg T, et al. Liver transplant from a donor with occult HEV infection induced chronic hepatitis and cirrhosis in the recipient. J Hepatol 2012; 56: 500-2.
53. Colson P, Borentain P, Queyriaux B, Kaba M, Moal V, Gallian P, Heyries L, et al. Pig liver sausage as a source of hepatitis E virus transmission to humans. J Infect Dis 2010; 202: 825-34.
54. Tei S, Kitajima N, Takahashi K, Mishiro S. Zoonotic transmission of hepatitis E virus from deer to human beings. Lancet 2003; 362: 371-3.
55. Izopet J, Dubois M, Bertagnoli S, Lhomme S, Marchandeau S, Boucher S, Kamar N, et al. Hepatitis e virus strains in rabbits and evidence of a closely related strain in humans, France. Emerg Infect Dis 2012; 18: 1274-81.
56. Johne R, Heckel G, Plenge-Bönig A, Kindler E, Maresch C, Reetz J, Schielke A, et al. Novel hepatitis E virus genotype in Norway rats, Germany. Emerg Infect Dis 2010; 16: 1452-5.
57. Johne R, Dremsek P, Kindler E, Schielke A, Plenge-Bönig A, Gregersen H, Wessels U, et al. Rat hepatitis E virus: geographical clustering within Germany and serological detection in wild Norway rats (Rattus norvegicus). Infect Genet Evol 2012; 12: 947-56.
58. Lack JB, Volk K, Van Den Bussche RA. Hepatitis e virus genotype 3 in wild rats, United States. Emerg Infect Dis 2012; 18: 1268-73.
59. Geng Y, Zhao C, Song A, Wang J, Zhang X, Harrison TJ, Zhou Y, et al. The serological prevalence and genetic diversity of hepatitis E virus in farmed rabbits in China. Infect Genet Evol 2011; 11: 476-82.
60. Zhao C, Ma Z, Harrison TJ, Feng R, Zhang C, Qiao Z, Fan J, et al. A novel genotype of hepatitis E virus prevalent among farmed rabbits in China. J Med Virol 2009; 81: 1371-9.
61. Takahashi M, Nishizawa T, Sato H, Sato Y, Jirintai, Nagashima S, Okamoto H. Analysis of the full-length genome of a hepatitis E virus isolate obtained from a wild boar in Japan that is classifiable into a novel genotype. J Gen Virol 2011; 92: 902-8.
62. Sato Y, Sato H, Naka K, Furuya S, Tsukiji H, Kitagawa K, Sonoda Y, et al. A nationwide survey of hepatitis E virus (HEV) infection in wild boars in Japan: identification of boar HEV strains of genotypes 3 and 4 and unrecognized genotypes. Arch Virol 2011; 156: 1345-58.
63. Galiana C, Fernández-Barredo S, García A, Gómez MT, Pérez-Gracia MT. Occupational exposure to hepatitis E virus (HEV) in swine workers. Am J Trop Med Hyg 2008; 78: 1012-5.
64. Rodriguez-Manzano J, Miagostovich M, Hundesa A, Clemente-Casares P, Carratala A, Buti M, Jardi R, et al. Analysis of the evolution in the circulation of HAV and HEV in eastern Spain by testing urban sewage samples. J Water Health 2010; 8: 346-5.
65. Berto A, Martelli F, Grierson S, Banks M. Hepatitis e virus in pork food chain, United kingdom, 2009-2010. Emerg Infect Dis 2012; 18: 1358-60.
66. Di Bartolo I, Diez-Valcarce M, Vasickova P, Kralik P, Hernandez M, Angeloni G, Ostanello F, et al. Hepatitis E virus in pork production chain in Czech Republic, Italy, and Spain, 2010. Emerg Infect Dis 2012; 18: 1282-9.
67. Bhatia V, Singhal A, Panda SK, Acharya SK. A 20-year single- center experience with acute liver failure during pregnancy: is the prognosis really worse? Hepatology 2008; 48: 1577-85.
68. Khuroo MS, Kamili, Jameel S. Vertical transmission of hepatitis E virus. Lancet 1995; 345: 1025-6.
69. Aggarwal R, Naik S. Epidemiology of hepatitis E: Current status. J Gastroentgerol Hepatol 2009; 24: 1484-93.
70. Kamar N, Mansuy JM, Cointault O, Selves J, Abravanel F, Danjoux M, Otal P, et al. Hepatitis E virus-related cirrhosis in kidney- and kidney-pancreas-transplant recipients. Am J Transplant 2008; 8: 1744-8.
71. Hamid S, Atiq M, Shehzad F, Yasmeen A, Nissa T, Salam A, Siddiqui A, et al. Hepatitis E virus superinfection in patients with chronic liver disease. Hepatology 2002; 36: 474-8.
72. Gerolami R, Moal V, Picard C, Colson P. Hepatitis E virus as an emerging cause of chronic liver disease in organ transplant recipients. J Hepatol 2009; 50: 622-4.
73. Abravanel F, Mansuy JM, Huynh A, Kamar N, Alric L, Peron JM, Récher C, et al. Low risk of hepatitis E virus reactivation after haematopoietic stem cell transplantation. J Clin Virol 2012; 54: 152-5.
74. Koenecke C, Pischke S, Heim A, Raggub L, Bremer B, Raupach R, Buchholz S, et al. Chronic hepatitis E in hematopoietic stem cell transplant patients in a low-endemic country? Transpl Infect Dis 2012; 14: 103-6.
75. Legrand-Abravanel F, Kamar N, Sandres-Saune K, Garrouste C, Dubois M, Mansuy JM, Muscari F, et al. Characteristics of autochthonous hepatitis E virus infection in solid-organ transplant recipients in France. J Infect Dis 2010; 202: 835-44.
76. Sood A, Midha V, Sood N. Guillain-Barré syndrome with acute hepatitis E. Am J Gastroenterol 2000; 95: 3667-8.
77. Kamar N, Bendall RP, Peron JM, Cintas P, Prudhomme L, Mansuy JM, Rostaing L, et al. Hepatitis E Virus and neurologic disorders. Emerg Infect Dis 2011; 17: 173-9.
78. Del Bello A, Arné-Bes MC, Lavayssière L, Kamar N. Hepatitis E virus-induced severe myositis. J Hepatol 2012; 57: 1152-3.
79. Fourquet E, Mansuy JM, Bureau C, Recher C, Vinel JP, Izopet J, Péron JM. Severe thrombocytopenia associated with acute autochthonous hepatitis E. J Clin Virol 2010; 48: 73-4.
80. Li C, Wang HF. Hepatitis E virus-related acute liver failure associated with pure red cell aplasia. Hepatobiliary Pancreat Dis Int 2011; 10: 557-8.
81. Shah SA, Lal A, Idrees M, Hussain A, Jeet C, Malik FA, Iqbal Z, et al. Hepatitis E virus-associated aplastic anaemia: the first case of its kind. J Clin Virol 2012; 54: 96-7.
82. Khudyakov Y, Kamili S. Serological dianostics of hepatitis E virus infection. Virus Res 2011; 161: 84-92.
83. Aggarwal R. Clinical presentation of hepatitis E. Virus Res 2011; 161: 15-22.
84. Kamar N, Garrousgte C, Haagsma EB, Garrigue V, Pischke S, Chauvert C, Dumortier J, et al. Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. Gastroenterology 2011; 140: 1481-9.
85. Gerolami R, Borentain P, Raissouni F, Motte A, Solas C, Colson P. Treatment of severe acute hepatitis E by ribavirin. J Clin Virol 2011; 52: 60-2.
86. Péron JM. Acute autochthonous hepatitis E in western patients with underlying chronic liver disease: A role for ribavirin? J Hepat 2011; 54: 1323-4.
87. Péron JM, Bureau C, Poirson H, Mansuy JM, Alric L, Selves J, Dupuis E, et al. Fulminant liver failure from acute autochthonous hepatitis E in France: description of seven patients with acute hepatitis E and encephalopathy. J Viral Hepat 2007; 14: 298-303.
88. Dalton HR, Hazeldine S, Banks M, Ljaz S, Bendall R. Locally acquired hepatitis E in chronic liver disease. Lancet 2007; 369: 1260.
89. Barnaud E, Rogée S, Garry P, Rose N, Pavio N. Thermal inactivation of infectious hepatitis E virus in experimentally contaminated food. Appl Environ Microbiol 2012; 78: 5153-9.
90. Xu C, Alter HJ. An assessment of HEV prevalence and risk in U.S. blood donors and recipients. Available from: (http://www3.niddk.nih.gov/fund/other/HepE2012/HepatitisE2012ProgramBook.pdf
91. Zhou YH, Purcell RH, Emerson SU. A truncated ORF2 protein contains the most immunogenic site on ORF2: antibody responses to non-vaccine sequences following challenge of vaccinated and non-vaccinated macaques with hepatitis E virus. Vaccine 2005; 23: 3157-65.
92. Shrestha MP, Scott RM, Joshi DM, Mammen MP Jr, Thapa GB, Thapa N, Myint KS, et al. Safety and efficacy of a recombinant hepatitis E vaccine. N Engl J Med 2007; 356: 895-903.
93. Zhu FC, Zhang J, Zhang XF, Zhou C, Wang ZZ, Huang SJ, Wang H, et al. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet 2010; 376: 895-902.
94. Wu T, Zhu FC, Huang SJ, Zhang XF, Wang ZZ, Zhang J, Xia NS. Safety of the hepatitis E vaccine for pregnant women: a preliminary analysis. Hepatology 2012; 55: 2038.